Yu, Tingting
Zhang, Yiwei
Li, Jiawen
Li, Zhuo
Tong, Rui
Funding for this research was provided by:
The Beijing Heathco Clinical Oncology Research Foundation (Y-SY201901-0198)
Article History
Received: 28 December 2023
Accepted: 31 March 2024
First Online: 21 June 2024
Declarations
:
: This study is a sub-project of the project “Efficacy Analysis and Prognosis Study of simultaneous chemoradiotherapy in the early stage of endogenic and cervical squamous cell carcinoma compared with surgical treatment”, which has passed the ethical review of our hospital. The ethical approval date was December 16th, 2020. The ethical approval number is 20201213P.Written informed consent was obtained from individual or guardian participants.
: Not applicable.
: All the authors declare that there is no conflict of interest. The data are all raw data, with no fraud. The first author is Yu Tingting; The corresponding author is Tong Rui (E-mail:1547536636@qq.Com)